Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors

This study is currently recruiting participants.

Study NCT00415571 Information provided by QuatRx Pharmaceuticals Company

First Received: December 21, 2006 Last Updated: February 29, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2007
Estimated Primary Completion Date:	No date given